GSK Loads up the Potential Milestones from Chemocentryx

By Business Review Editor

Pharma Deals Review: Vol 2006 Issue 76 (Table of Contents)

Published: 6 Oct-2006

DOI: 10.3833/pdr.v2006.i76.447     ISSN: 1756-7874

Section: Licensing

Fulltext:

Abstract

GlaxoSmithKline and ChemoCentryx entered into license agreement to discover, develop and market drugs for treating various inflammatory diseases...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details